Author:
Yin Li,Li Zhengyuan,Zhan Wenjuan,Kang Yuanjie,Tian Qian,Li Dan,Zhang Huifang
Abstract
Abstract
Introduction
Incontinentia pigmenti (IP) is a rare neuroectodermal dysplasia caused by a defect in the IKBKG gene. The pathogenesis of central nervous system injury is believed to be related to microvascular ischemia. Currently, few treatment strategies are available for the inflammatory phase.
Materials and methods
This retrospective descriptive analysis included the clinical data of 41 children with IP collected from 2007 to 2021 in Xi’an, China, comprising clinical characteristics, imaging findings, blood cell analysis, skin histopathology, and genetic data.
Results
Fourteen children (34%) aged 4 days to 5 months exhibited clinical signs and symptoms, including convulsions, delayed psychomotor development following neurological damage, and revealed significant MRI abnormalities, including ischemia, hypoxia, cerebral hypoperfusion, hemorrhage, encephalomalacia, and cerebral atrophy. Eight of the 24 patients (33%) presented with retinal vascular tortuosity and telangiectasis, accompanied by neovascularization and hemorrhage. Thirty-eight children (93%) had elevated eosinophils (mean: 3.63 ± 4.46 × 109), and 28 children (68%) had significantly elevated platelets (mean: 420.16 ± 179.43 × 109). Histopathology of skin revealed microvascular extravasation and vasodilation with perivascular and intravascular eosinophilic infiltration.
Conclusion
Brain injury in IP occurs during infancy until 5 months of age, which is also the acute dermatitis phase accompanied by eosinophilia and an increased platelet count. This study provides evidence of microvascular damage to the skin and fundus during the inflammatory phase. The mechanism of microvascular damage may be similar to that in the brain.
Funder
Natural Science Foundation of Shaanxi Province
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30(1):53–9.
2. Yadlapati S, Tripathy K. Incontinentia pigmenti (Bloch Sulzberger Syndrome) [Updated 2022 Aug 22]. Treasure Island (FL): StatPearls Publishing; 2022.
3. Cammarata-Scalisi F, Fusco F, Ursini MV. Incontinentia Pigmenti. Actas Dermosifiliogr. 2019;110(4):273–8.
4. How KN, Leong HJY, Pramono ZAD, Leong KF, Lai ZW, Yap WH. Uncovering incontinentia pigmenti: from DNA sequence to pathophysiology. Front Pediatr. 2022;10:900606.
5. Scheuerle AE, Ursini M. Incontinentia pigmenti (Synonym: Bloch-Sulzberger Syndrome). Seattle: University of Washington; 1999.